NASDAQ:CRBP

Corbus Pharmaceuticals Earning Date

USA |NASDAQ |USD

CRBP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.11 $-0.15 $-0.43
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $650.00K $136.56K $1.23M

Corbus Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CRBP Earnings Date & History Chart

CRBP Earnings & Revenue Forecast

CRBP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.10 $-0.13 $-0.08
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.50 $-0.55 $-0.45
Dec 2022 4 $-0.46 $-0.59 $-0.29

CRBP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.10 $-0.12 $-0.10
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.50 $-0.52 $-0.47
Dec 2022 0 / 0 $-0.46 $-0.47 $-0.42

CRBP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $780.00K $0.00 $1.34M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $2.22M $800.00K $3.08M
Dec 2022 4 $11.11M $0.00 $25.00M

CRBP Earnings Date & Revenue History

CRBP Earnings History

|
Show More
Show More

CRBP Revenue History

|
Show More
Show More

Corbus Pharmaceuticals Next Earnings Date & Report

CRBP Next Earnings Date & Report Preview: Sep 2021 (FQ)

CRBP's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Corbus Pharmaceuticals's next quarterly earnings is $-0.11, with a low EPS estimation of $-0.13, and a high estimation of $-0.09.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.11, the last 2 month trend is $-0.13, and the 3 month trend is $-0.11.

Based on 3 analysts, the average revenue estimation is $650.00K, with a low revenue estimation of $0.00, and a high estimation of $1.00M.

Corbus Pharmaceuticals Previous Earnings Dates & Reports

CRBP Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Corbus Pharmaceuticals's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

CRBP's earnings per share (EPS) was $-0.15, missing the consensus analysts forecast of $-0.13 by -20.00%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 7.14%, and higher than the same period a year before (Jun 2020) by -71.15%.

Revenues were $136.56K, worse than the forecast of $137.00K by -0.32%, down by -78.92% from the previous quarter , and down by -52.31% from the same period last year.

The company reported a net income of $-17.14M.

Free cash flow for the quarter was $-17.53M , compared to $-21.81M last quarter and $-26.62M a year before.

CRBP ended the quarter with $26.09M in total debt, a decrease of -1.44% compared to the previous quarter, and an increase of 203.61% compared to the same quarter a year before.

CRBP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Corbus Pharmaceuticals's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.

CRBP's earnings per share (EPS) was $-1.48, beating the consensus analysts forecast of $-1.61 by -8.07% , and lower than the previous year's EPS (Dec 2019) by 30.97%.

Revenues were $3.94M, worse than the forecast of $4.77M by -17.46%, and down by -89.11% from previous year's revenue.

The company reported a net income of $-111.27M.

Corbus Pharmaceuticals reported a free cash flow of $-100.17M for its fiscal year, compared to $-48.46M a year ago.

The company ended the fiscal year with $19.74M in total debt, an increase of 109.02% compared to the previous year.